1:27 am ISIS Pharm reports interim results from ISIS-SMN Rx Phase 2 study in infants with spinal muscular atrophy
View todays social media effects on ISIS
View the latest stocks trending across Twitter. Click to view dashboard
See who Isis is hiring next, click here to view
